B. Combes, J. Shorey, and A. Barrera, Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane, Lancet, vol.2, pp.234-237, 1971.

G. Xu and T. Huang, Hepatitis B virus-associated glomerular nephritis in East Asia: progress and challenges, Eur J Intern Med, vol.22, pp.161-166, 2011.

R. Bhimma and H. M. Coovadia, Hepatitis B virus-associated nephropathy, Am J Nephrol, vol.24, pp.198-211, 2004.

R. J. Johnson and W. G. Couser, Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations, Kidney Int, vol.37, pp.663-676, 1990.

K. N. Lai, P. K. Li, and S. F. Lui, Membranous nephropathy related to hepatitis B virus in adults, N Engl J Med, vol.324, pp.1457-1463, 1991.

K. N. Lai, R. T. Ho, J. S. Tam, and F. M. Lai, Detection of hepatitis B virus DNA and RNA in kidneys of HBV related glomerulonephritis, Kidney Int, vol.50, pp.1965-1977, 1996.

M. T. Liao, M. H. Chang, and F. G. Lin, Universal hepatitis B vaccination reduces childhood hepatitis B virus-associated membranous nephropathy, Pediatrics, vol.128, pp.600-604, 2011.

R. J. Burnett, A. Kramvis, C. Dochez, and A. Meheus, An update after 16 years of hepatitis B vaccination in South Africa, Vaccine, vol.7, issue.3, pp.45-51, 2012.

Y. Yang, Y. P. Ma, and D. P. Chen, A meta-analysis of antiviral therapy for hepatitis B virus-associated membranous nephropathy, PLoS One, vol.11, p.160437, 2016.

L. H. Beck, R. G. Bonegio, and G. Lambeau, M-type phospholipase A2 receptor as target antigen in idiopathic MN, N Engl J Med, vol.361, pp.11-21, 2009.

P. Ronco and H. Debiec, Pathophysiological advances in membranous nephropathy: time for a shift in patient's care. Lancet, vol.385, pp.1983-1992, 2015.

T. Stehle, V. Audard, P. Ronco, and H. Debiec, Phospholipase A2 receptor and sarcoidosis-associated membranous nephropathy, Nephrol Dial Transplant, vol.30, pp.1047-1050, 2015.

H. Debiec and P. Ronco, PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy, N Engl J Med, vol.364, pp.689-690, 2011.

E. Hoxha, U. Kneissler, and G. Stege, Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy, Kidney Int, vol.82, pp.797-804, 2012.

B. Svobodova, E. Honsova, and P. Ronco, Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy, Nephrol Dial Transplant, vol.28, pp.1839-1844, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00919114

M. Knehtl, H. Debiec, and P. Kamgang, A case of phospholipase A(2) receptor-positive membranous nephropathy preceding sarcoid-associated granulomatous tubulointerstitial nephritis, Am J Kidney Dis, vol.57, pp.140-143, 2011.

C. P. Larsen, N. C. Messias, and F. G. Silva, Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies, Mod Pathol, vol.26, pp.709-715, 2013.

Q. Xie, Y. Li, and J. Xue, Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy, Am J Nephrol, vol.41, pp.345-353, 2015.

X. Y. Zheng, R. B. Wei, and L. Tang, Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis, World J Gastroenterol, vol.18, pp.821-832, 2012.

U. Elewa, A. M. Sandri, W. R. Kim, and F. C. Fervenza, Treatment of hepatitis B virus-associated nephropathy, Nephron Clin Pract, vol.119, pp.41-49, 2011.

D. Kong, D. Wu, and T. Wang, Detection of viral antigens in renal tissue of glomerulonephritis patients without

A. S. Lai and K. N. Lai, Viral nephropathy, Nat Clin Pract Nephrol, vol.2, pp.254-262, 2006.

D. Vergani and G. Mieli-vergani, Autoimmune manifestations in viral hepatitis, Semin Immunopathol, vol.35, pp.73-85, 2013.

P. Cacoub and B. Terrier, Hepatitis B-related autoimmune manifestations, Rheum Dis Clin North Am, vol.35, pp.125-137, 2009.

G. V. Gregorio, K. Choudhuri, and Y. Ma, Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection, J Immunol, vol.162, pp.1802-1810, 1999.

M. Fresquet, T. A. Jowitt, and J. Gummadova, Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy, J Am Soc Nephrol, vol.26, pp.302-313, 2015.

P. Pontisso, M. C. Poon, P. Tiollais, and C. Brechot, Detection of hepatitis B virus DNA in mononuclear blood cells, Br Med J. [Clin Res Ed], vol.288, pp.1563-1566, 1984.

D. Bisceglie, A. M. Lok, A. S. Martin, and P. , Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: just the tip of the iceberg?, Hepatology, vol.61, pp.703-711, 2015.

A. Nakaya, S. Fujita, and A. Satake, Delayed HBV reactivation in rituximab-containing chemotherapy: how long should we continue anti-virus prophylaxis or monitoring HBV-DNA?, Leuk Res, vol.50, pp.46-49, 2016.

L. Allweiss and M. Dandri, The role of cccDNA in HBV maintenance, Viruses, vol.9, p.156, 2017.